Vanguard Group Inc Omega Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OMGA
# of Institutions
73Shares Held
45.8MCall Options Held
45.1KPut Options Held
75.3K-
Flagship Pioneering Inc. Cambridge, MA29.2MShares$60.5 Million7.03% of portfolio
-
Harbourvest Partners LLC Boston, MA3.51MShares$7.27 Million5.96% of portfolio
-
State Of Wisconsin Investment Board Madison, WI1.86MShares$3.84 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.42MShares$2.93 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N41.32MShares$2.74 Million0.26% of portfolio
About Omega Therapeutics, Inc.
- Ticker OMGA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,853,400
- Market Cap $99.1M
- Description
- Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...